FDA Approves Theranica's Nerivio(R) for Acute Treatment of Migraine in Adolescents

VThe Prescribed Wearable Device is Now indicated for Patients 12 Years Old and Above NETANYA, Israel and MONTCLAIR, N.J., Jan. 25, 2021 -- (Healthcare Sales & Marketing Network) -- Theranica, a prescribed digital therapeutics (PDT) company developing a... Devices, Neurology, FDA Theranica , prescribed digital therapeutics, Nerivio , migraine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news